Clinical Lab Reimbursement Experts Discuss PAMA Pressure and Leaving Money on the Table
Attorney Danielle Tangorre and TELCOR’s Darla Wanitschke answered questions during webinar
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
Attorney Danielle Tangorre and TELCOR’s Darla Wanitschke answered questions during webinar
How automation, artificial intelligence, and other emerging technologies are elevating the efficiency and output of labs’ revenue cycles
With the rule recently struck down by a Texas court, how should employers, including labs, handle such agreements going forward?
A PT update went into effect on January 1, focusing on revised acceptance limits, among other modifications
Earle S. Collum, chair of the CAP Council on Accreditation, talks through regulatory changes in 2024 and what to expect from 2025
Revenue cycle management experts weigh in on the biggest developments of 2024 and how labs can best prepare for 2025 and beyond
Cases filed or resolved by the U.S. Department of Justice in the fourth quarter reveal the same compliance issues from early in 2024
ADLM president Anthony Killeen looks at labs’ staffing struggles in 2024 and what can be done to alleviate them in the coming year
Although the timelines have been extended several times, IVDR complexity has created a concerning bottleneck in the approval process
Recent False Claims Act settlements underscore the government’s emphasis on individual accountability in healthcare fraud matters
The potential occupational safety pros and cons of artificial intelligence implementation into the clinical lab